Dapcise 10 Tablet
Marketer
Cadsol Life Sciences LLP
Salt Composition
Dapagliflozin (10mg)
Overview Dapcise 10 Tablet
Glyciphase 10mg tablets are indicated for monotherapy or combination therapy in managing type 2 diabetes mellitus. They effectively regulate elevated blood glucose, thereby mitigating the risk of severe diabetic complications and cardiovascular events. Glyciphase 10mg may be administered with or without food, but consistent daily timing is recommended; dosage is determined by your physician. Discontinuing treatment without medical consultation can lead to hyperglycemia and potential complications such as nephropathy and retinopathy. This medication forms part of a comprehensive diabetes management plan, encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Frequently reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Potential dehydration necessitates increased fluid intake. Practicing good hygiene reduces the likelihood of genital fungal infections. Prior to commencing treatment, disclose any kidney or liver impairment, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Excessive alcohol consumption should be avoided due to the increased risk of adverse reactions. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapcise 10 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Dapcise 10 Tablet
Managing type 2 diabetes
Major Benefits of Dapcise 10 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapcise 10 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapcise 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapcise 10 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapcise 10 Tablet can be consumed with or without food; however, consistent timing is recommended.
How Dapcise 10 Tablet works:
Dapcise 10 tablets are used to manage diabetes. Their mechanism involves facilitating the excretion of surplus glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dapcise 10 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapcise 10 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapcise 10 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Dapcise 10 Tablet due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapcise 10 Tablet poses no safety concerns for individuals with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dapcise 10 Tablet :
Should you forget a Dapcise 10 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Dapcise 10 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |



